300119.SZ
Tianjin Ringpu Bio-technology Co., Ltd.
SZSE · Healthcare · C 制造业 · CN
CNY 17.34
−3.24%Price chart
Aug 20Aug 25Aug 28Sep 2Sep 7Sep 10Sep 15Sep 18
Key dataSep 18, 2026
OpenCNY 17.29
From 52W high−23.14%
Volume6.30M
Market capCNY 8.06B
P/E (TTM)20.1x
P/S (TTM)2.3x
Div yield2.39%
Key dataSep 18, 2026
Open
CNY 17.29
From 52W high
−23.14%
Volume
6.30M
Market cap
CNY 8.06B
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
12.9x
P/E (TTM)
20.1x
RSI (14)
40.2
MomentumView details →
1D Return
−3.24%
YTD Return
−10.71%
Similar companies
Latest newsMore news →
Ruipu Biology announced that two avian influenza vaccines passed the Ministry of Agriculture and Rural Affairs' review for production strain change filing.21d agoRuipu Biology announced its 2026 first-half results: net profit attributable to shareholders was 204 million yuan, down 20.43% year-on-year, with revenue of 1.72 billion yuan, up 0.75%.27d ago